key: cord-1017576-n7laihca
authors: Dash, Siddhartha; Behera, Biswanath; Sethy, Madhusmita; Mishra, Jeebanjyoti; Garg, Sonika
title: COVID‐19 vaccine‐induced urticarial vasculitis
date: 2021-08-14
journal: Dermatol Ther
DOI: 10.1111/dth.15093
sha: 0e7ec98fac8b9d51cc6807ca688befc42b79748c
doc_id: 1017576
cord_uid: n7laihca

nan

Dear Editor, Urticarial vasculitis (UV) is characterized by persistent urticarial rashes that last for more than 24 h and heals with hyperpigmentation. It can be idiopathic or due to drugs, infections, malignancy, autoimmune or autoinflammatory diseases. 1 

Treatment of urticarial vasculitis: a systematic review

Urticarial vasculitis secondary to H1N1 vaccination

Urticarial vasculitis after influenza vaccination

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registrybased study of 414 cases

CD4+ T cells sensitized by vascular smooth muscle induce vasculitis, and interferon gamma is critical for the initiation of vascular pathology

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Drug-induced vasculitis: a clinical and pathological review

Vasculitis following HPV immunization